232 related articles for article (PubMed ID: 32150899)
1. Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals.
Rautamo M; Kvarnström K; Sivén M; Airaksinen M; Lahdenne P; Sandler N
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32150899
[TBL] [Abstract][Full Text] [Related]
2. Towards Printed Pediatric Medicines in Hospital Pharmacies: Comparison of 2D and 3D-Printed Orodispersible Warfarin Films with Conventional Oral Powders in Unit Dose Sachets.
Öblom H; Sjöholm E; Rautamo M; Sandler N
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31337146
[TBL] [Abstract][Full Text] [Related]
3. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing?
Andreadis II; Gioumouxouzis CI; Eleftheriadis GK; Fatouros DG
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335984
[TBL] [Abstract][Full Text] [Related]
4. Preferences of Healthcare Professionals on 3D-Printed Tablets: A Pilot Study.
Goh O; Goh WJ; Lim SH; Hoo GS; Liew R; Ng TM
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890417
[TBL] [Abstract][Full Text] [Related]
5. A new chapter in pharmaceutical manufacturing: 3D-printed drug products.
Norman J; Madurawe RD; Moore CM; Khan MA; Khairuzzaman A
Adv Drug Deliv Rev; 2017 Jan; 108():39-50. PubMed ID: 27001902
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on 3D printed personalized medicines for pediatrics.
Tong H; Zhang J; Ma J; Zhang J
Int J Pharm; 2024 Mar; 653():123867. PubMed ID: 38310991
[TBL] [Abstract][Full Text] [Related]
7. Scenarios for 3D printing of personalized medicines - A case study.
Beer N; Hegger I; Kaae S; De Bruin ML; Genina N; Alves TL; Hoebert J; Kälvemark Sporrong S
Explor Res Clin Soc Pharm; 2021 Dec; 4():100073. PubMed ID: 35479838
[TBL] [Abstract][Full Text] [Related]
8. 3D printed drug delivery devices: perspectives and technical challenges.
Palo M; Holländer J; Suominen J; Yliruusi J; Sandler N
Expert Rev Med Devices; 2017 Sep; 14(9):685-696. PubMed ID: 28774216
[TBL] [Abstract][Full Text] [Related]
9. Vat photopolymerization 3D printing for advanced drug delivery and medical device applications.
Xu X; Awad A; Robles-Martinez P; Gaisford S; Goyanes A; Basit AW
J Control Release; 2021 Jan; 329():743-757. PubMed ID: 33031881
[TBL] [Abstract][Full Text] [Related]
10. 3D printing in the design of pharmaceutical dosage forms.
Souto EB; Campos JC; Filho SC; Teixeira MC; Martins-Gomes C; Zielinska A; Carbone C; Silva AM
Pharm Dev Technol; 2019 Oct; 24(8):1044-1053. PubMed ID: 31180272
[TBL] [Abstract][Full Text] [Related]
11. 3D printing of pharmaceuticals: approach from bench scale to commercial development.
Pawar R; Pawar A
Futur J Pharm Sci; 2022; 8(1):48. PubMed ID: 36466365
[TBL] [Abstract][Full Text] [Related]
12. 3D Printing Technology in Drug Delivery: Recent Progress and Application.
Kotta S; Nair A; Alsabeelah N
Curr Pharm Des; 2018; 24(42):5039-5048. PubMed ID: 30520368
[TBL] [Abstract][Full Text] [Related]
13. Additive Manufacturing with 3D Printing: Progress from Bench to Bedside.
Rahman Z; Barakh Ali SF; Ozkan T; Charoo NA; Reddy IK; Khan MA
AAPS J; 2018 Sep; 20(6):101. PubMed ID: 30209693
[TBL] [Abstract][Full Text] [Related]
14. Perceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: a pilot study.
Fastø MM; Genina N; Kaae S; Kälvemark Sporrong S
Int J Clin Pharm; 2019 Oct; 41(5):1290-1298. PubMed ID: 31444687
[TBL] [Abstract][Full Text] [Related]
15. 3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?-A Scoping Review.
Lafeber I; Ruijgrok EJ; Guchelaar HJ; Schimmel KJM
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214148
[TBL] [Abstract][Full Text] [Related]
16. Shaping the future: recent advances of 3D printing in drug delivery and healthcare.
Trenfield SJ; Awad A; Madla CM; Hatton GB; Firth J; Goyanes A; Gaisford S; Basit AW
Expert Opin Drug Deliv; 2019 Oct; 16(10):1081-1094. PubMed ID: 31478752
[No Abstract] [Full Text] [Related]
17. Analytical aspects of printed oral dosage forms.
Edinger M; Jacobsen J; Bar-Shalom D; Rantanen J; Genina N
Int J Pharm; 2018 Dec; 553(1-2):97-108. PubMed ID: 30316794
[TBL] [Abstract][Full Text] [Related]
18. 3D printing for drug manufacturing: A perspective on the future of pharmaceuticals.
Lepowsky E; Tasoglu S
Int J Bioprint; 2018; 4(1):119. PubMed ID: 33102905
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Formulations Developed by Extrusion-Based 3D Printing: From Past Discoveries to Future Prospects.
Ianno V; Vurpillot S; Prillieux S; Espeau P
Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675103
[TBL] [Abstract][Full Text] [Related]
20. 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges.
Warsi MH; Yusuf M; Al Robaian M; Khan M; Muheem A; Khan S
Curr Pharm Des; 2018; 24(42):4949-4956. PubMed ID: 30520367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
